GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market
Links shared publicly online about this topic.
- 1,021total visits
GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
View full resource at news-medical.net
Tags: Diabetes Type 2 Medication, Diabetes Medication, Stroke, Joint, Drug, FDA, Avandia, GlaxoSmithKline
Most Recently Shared on July 15, 2010 at 12:08 pm By:
Pregnancy News: GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market: GlaxoSmithKli... http://bit.ly/9XEuGh
Also Shared By:
GlaxoSmithKline statement in response to FDA Advisory Committees’ vote on safety of Avandia® (rosiglitazone)
us.gsk.com — “GlaxoSmithKline [NYSE: GSK] confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market.” View full resource at us.gsk.com
Most Recently Shared on July 15, 2010 at 1:32 pm By:
eyeonfda Pharma and Health Lawyer
GSK statement in response to FDA Advisory Committees’ vote on safety of Avandia® http://ow.ly/2bRny
Advertisement
News-Medical.Net
@NewsMedical
GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market: GlaxoSmithKline confirmed tod... http://bit.ly/9XEuGh
1 year ago...